MREO
Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)
1.95 / 10
Underperform
Technical score is 1.95/10, classified as Underperform. All three candlestick signals—Marubozu White, Long Lower Shadow, Long Upper Shadow—are bearish, yielding low win rates and negative average returns. The market exhibits weak momentum and heightened downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score3.06/10
Win Rate43.75%
Hist. Signals64
Avg Return2.20%
Score3.06/10
Win Rate43.75%
Hist. Signals64
Avg Return2.20%
Marubozu White
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-1.17%
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-1.17%
Long Upper Shadow
Score1.8/10
Win Rate39.58%
Hist. Signals48
Avg Return0.73%
Score1.8/10
Win Rate39.58%
Hist. Signals48
Avg Return0.73%
Long Lower Shadow
Score3.06/10
Win Rate43.75%
Hist. Signals64
Avg Return2.20%
Score3.06/10
Win Rate43.75%
Hist. Signals64
Avg Return2.20%
Long Upper Shadow
Score1.8/10
Win Rate39.58%
Hist. Signals48
Avg Return0.73%
Score1.8/10
Win Rate39.58%
Hist. Signals48
Avg Return0.73%
Marubozu White
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-1.17%
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-1.17%
What is the current technical signals for MREO?
- MREO presents a Underperform setup with a Technical Score of 1.95/10. Key technical indicators highlight an RSI of 37.73 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 0.43. Traders should monitor key support at 0.33 and resistance at 0.34.
